Skip to main content
University of California San Francisco
UCSF Health
Search UCSF
About UCSF
Search form
Search...
Home
Treg Products
Clinical Trials
People
Contact
CT group
You are here
Home
>
Diabetes
Diabetes
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.
Targeting CD22 reprograms B-cells and reverses autoimmune diabetes.
Regulated beta-cell regeneration in the adult mouse pancreas.
Regulated beta-cell regeneration in the adult mouse pancreas.
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
Analysis of T-cell assays to measure autoimmune responses in subjects with type 1 diabetes: results of a blinded controlled study.
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.
Insulin secretion in type 1 diabetes.
Insulin secretion in type 1 diabetes.
Pages
« first
‹ previous
1
2
3
4
next ›
last »